{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:40:57Z","timestamp":1792719657504,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T00:00:00Z","timestamp":1418083200000},"content-version":"vor","delay-in-days":373,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cancercell.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ccr.2013.10.013","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T10:33:44Z","timestamp":1386585224000},"page":"751-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":555,"title":["Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models"],"prefix":"10.1016","volume":"24","author":[{"given":"Ruth","family":"Perets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory\u00a0A.","family":"Wyant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine\u00a0W.","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan\u00a0G.","family":"Bijron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barish\u00a0B.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth\u00a0T.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin\u00a0Yun\u00a0H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders\u00a0W.","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey\u00a0D.","family":"Stepule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soongu","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison\u00a0M.","family":"Karst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle\u00a0S.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita\u00a0R.","family":"Setlur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher\u00a0P.","family":"Crum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela\u00a0M.","family":"Dinulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Drapkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2013.10.013_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib2","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"10 Suppl","key":"10.1016\/j.ccr.2013.10.013_bib3","doi-asserted-by":"crossref","first-page":"200s","DOI":"10.1200\/JCO.2003.01.068","article-title":"Status of tumor markers in ovarian cancer screening","volume":"21","author":"Bast","year":"2003","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2013.10.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12036","article-title":"Phosphoinositide 3-kinase and INPP4B in human breast cancer","volume":"1280","author":"Bertucci","year":"2013","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1016\/j.ccr.2013.10.013_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccr.2013.10.013_bib6","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.10.013_bib7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccr.2013.10.013_bib8","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-12-3947","article-title":"Early telomere shortening and genomic instability in tubo-ovarian preneoplastic lesions","volume":"19","author":"Chene","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2013.10.013_bib9","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1073\/pnas.1109363108","article-title":"Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer","volume":"108","author":"Cheung","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2013.10.013_bib10","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.yexcr.2006.09.026","article-title":"Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes","volume":"313","author":"Clark-Knowles","year":"2007","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ccr.2013.10.013_bib11","doi-asserted-by":"crossref","first-page":"e8534","DOI":"10.1371\/journal.pone.0008534","article-title":"Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas","volume":"4","author":"Clark-Knowles","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ccr.2013.10.013_bib12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1470-2045(11)70222-4","article-title":"The\u00a0tubal hypothesis of ovarian cancer: caution needed","volume":"12","author":"Collins","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ccr.2013.10.013_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nm1173","article-title":"Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer","volume":"11","author":"Dinulescu","year":"2005","journal-title":"Nat. Med."},{"issue":"Database issue","key":"10.1016\/j.ccr.2013.10.013_bib14","doi-asserted-by":"crossref","first-page":"D881","DOI":"10.1093\/nar\/gkr974","article-title":"The Mouse Genome Database (MGD): comprehensive resource for genetics and genomics of the laboratory mouse","volume":"40","author":"Eppig","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccr.2013.10.013_bib15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.10.013_bib16","first-page":"3459","article-title":"Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium","volume":"63","author":"Flesken-Nikitin","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2013.10.013_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nature11979","article-title":"Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche","volume":"495","author":"Flesken-Nikitin","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2013.10.013_bib18","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccr.2013.10.013_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccr.2013.10.013_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ccr.2009.06.006","article-title":"Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling","volume":"16","author":"Gewinner","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2013.10.013_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1593\/neo.11138","article-title":"Molecular requirements for transformation of fallopian tube epithelial cells into serous carcinoma","volume":"13","author":"Jazaeri","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.ccr.2013.10.013_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"Jonkers","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2013.10.013_bib23","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2013.10.013_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2011.05.021","article-title":"Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas","volume":"123","author":"Karst","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccr.2013.10.013_bib25","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2013.10.013_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1172\/JCI59309","article-title":"An\u00a0activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice","volume":"122","author":"Kinross","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ccr.2013.10.013_bib28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/modpathol.2011.67","article-title":"Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma","volume":"24","author":"Kuhn","year":"2011","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib30","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib32","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":"Pathologic findings in prophylactic oophorectomy specimens in high-risk women","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ccr.2013.10.013_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/gene.10036","article-title":"Cre\/loxP-mediated inactivation of the murine Pten tumor suppressor gene","volume":"32","author":"Lesche","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.ccr.2013.10.013_bib34","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccr.2013.10.013_bib35","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ccr.2013.10.013_bib37","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1038\/onc.2011.70","article-title":"Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in\u00a0vivo","volume":"30","author":"Mullany","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2013.10.013_bib38","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"92","author":"Mutter","year":"2000","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccr.2013.10.013_bib39","first-page":"83","article-title":"Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers","volume":"10","author":"Nichols","year":"2001","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ccr.2013.10.013_bib40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","article-title":"Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome","volume":"119","author":"Olive","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2013.10.013_bib41","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1073\/pnas.152238499","article-title":"Early restriction of peripheral and proximal cell lineages during formation of the lung","volume":"99","author":"Perl","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2013.10.013_bib42","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1097\/PAS.0b013e3181ef7b16","article-title":"Are all pelvic (nonuterine) serous carcinomas of tubal origin?","volume":"34","author":"Przybycin","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib43","doi-asserted-by":"crossref","first-page":"e8404","DOI":"10.1371\/journal.pone.0008404","article-title":"Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53","volume":"4","author":"Quinn","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ccr.2013.10.013_bib44","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/modpathol.2010.119","article-title":"High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression","volume":"23","author":"Roh","year":"2010","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA\u00a0Cancer J. Clin."},{"key":"10.1016\/j.ccr.2013.10.013_bib46","first-page":"2485","article-title":"Distant metastases in ovarian cancer: association with p53 mutations","volume":"5","author":"Sood","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccr.2013.10.013_bib47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2013.10.013_bib48","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/0008-5472.CAN-11-3834","article-title":"Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer","volume":"72","author":"Szabova","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2013.10.013_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAI.0b013e3182025f66","article-title":"Expression of PAX8 in normal and neoplastic tissues: a comprehensive immunohistochemical study","volume":"19","author":"Tacha","year":"2011","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.ccr.2013.10.013_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nm.1865","article-title":"An\u00a0efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice","volume":"14","author":"Traykova-Brauch","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccr.2013.10.013_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2013.10.013_bib52","doi-asserted-by":"crossref","first-page":"e563","DOI":"10.1200\/JCO.2010.30.1010","article-title":"BRCA1 CpG island hypermethylation predicts sensitivity to poly(adenosine diphosphate)-ribose polymerase inhibitors","volume":"28","author":"Veeck","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ccr.2013.10.013_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2007.02.016","article-title":"Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt\/beta-catenin and PI3K\/Pten signaling pathways","volume":"11","author":"Wu","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2013.10.013_bib54","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ajpath.2012.12.031","article-title":"Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer","volume":"182","author":"Wu","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccr.2013.10.013_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/8743","article-title":"Conditional mutation of Brca1 in\u00a0mammary epithelial cells results in blunted ductal morphogenesis and tumour formation","volume":"22","author":"Xu","year":"1999","journal-title":"Nat. Genet."}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610813004595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610813004595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T16:25:21Z","timestamp":1597163121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610813004595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1535610813004595"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2013.10.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718206954.793527282","asserted-by":"object"}]},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccr.2013.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}